Back to Results

Scorpius Holdings Inc (SCPX)

Scorpius Holdings Inc. is a healthcare company listed on OTC Markets as common stock under the ticker SCPX. Through its subsidiary, Scorpius BioManufacturing, the company operates as an integrated contract development and manufacturing organization serving biotechnology and biopharmaceutical clients. Its activities include clinical and commercial drug substance manufacturing, release and stability testing, and a range of process development services. These services cover upstream and downstream development and optimization, analytical method development, and cell line development, testing, and characterization. Formerly known as NightHawk Biosciences, Inc., the company adopted its current name in February 2024. Scorpius Holdings was incorporated in 2008 and is based in San Antonio, Texas.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-SCPX
$0.0011
10.0% Upside
Fair
Not available
Not available
Weak
0.0%
November 17, 2026
61.142 K
11.928 M
144.6%
100.0%
-25.6
60.4%
Valuation • Fair Value

Scorpius Holdings Inc (OTC-SCPX) Fair Value by Valuation Model

Review the available estimates for Scorpius Holdings Inc (OTC-SCPX), including Comps Fair Value.

Primary Valuation Read

Fair Value

$0.0011

Estimated upside of 10.0% versus the current market price.

Fair Value Confidence

Very low

Confidence level for the primary fair value estimate.

Comps Fair Value

$0.0011

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 3 available valuation references for Scorpius Holdings Inc (OTC-SCPX) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Scorpius Holdings Inc (OTC-SCPX)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

1.716 M

Current operating scale indicator.

Revenue Forecast

16 M

Forward revenue estimate.

EBITDA

-21.761 M

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Scorpius Holdings Inc (OTC-SCPX) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Scorpius Holdings Inc (OTC-SCPX)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

1

Weak quality score that deserves closer review.

Beneish M-Score

1.17

Higher caution zone on this screen.

Altman Z-Score

-25.6

Lower score that deserves closer risk review.

FCF / Net Income

60.4%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Scorpius Holdings Inc (OTC-SCPX). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Scorpius Holdings Inc (OTC-SCPX)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 17, 2026

Days to Earnings

60

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Scorpius Holdings Inc (OTC-SCPX), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Scorpius Holdings Inc (OTC-SCPX) Stock Forecast & Technical Outlook

Review Scorpius Holdings Inc (OTC-SCPX) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Sell

The 15-minute technical read for Scorpius Holdings Inc (OTC-SCPX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Sell

The 1-hour technical read for Scorpius Holdings Inc (OTC-SCPX) is currently Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Scorpius Holdings Inc (OTC-SCPX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Scorpius Holdings Inc (OTC-SCPX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Scorpius Holdings Inc (OTC-SCPX) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Scorpius Holdings Inc (OTC-SCPX)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Scorpius Holdings Inc (OTC-SCPX) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ • Fast Investor Answers

Scorpius Holdings Inc (OTC-SCPX) Stock FAQ

Data-supported answers about Scorpius Holdings Inc (OTC-SCPX), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.0011
Estimated upside 10.0%
Valuation Rating
Undervalued
Estimated upside of 10.0%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Scorpius Holdings Inc (OTC-SCPX) is $0.0011. This implies an estimated upside of 10.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 10.0% versus the current market price.

The current financial health read for Scorpius Holdings Inc (OTC-SCPX) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Scorpius Holdings Inc (OTC-SCPX) is November 17, 2026.

The latest available data indicates no current dividend yield for Scorpius Holdings Inc (OTC-SCPX).

The current market capitalization listed for Scorpius Holdings Inc is 61.142 K.

The current enterprise value listed for Scorpius Holdings Inc is 11.928 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Scorpius Holdings Inc is OTC-SCPX, and the stock is listed on OTC Markets.

Scorpius Holdings Inc (OTC-SCPX) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Scorpius Holdings Inc is 144.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Scorpius Holdings Inc is 100.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Biotechnology Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

ABBV NYSE AbbVie Inc Fair Value Fair Market Cap 466.4 B
AMGN NASDAQ Amgen Inc Fair Value Fair Market Cap 208.5 B
GILD NASDAQ Gilead Sciences Inc Fair Value Fair Market Cap 186 B
VRTX NASDAQ Vertex Pharmaceuticals Inc Fair Value Fair Market Cap 128.8 B
REGN NASDAQ Regeneron Pharmaceuticals Inc Fair Value Undervalued Market Cap 78.353 B
ARGX NASDAQ argenx NV ADR Fair Value Fair Market Cap 62.595 B
MRNA NASDAQ Moderna Inc Fair Value Overvalued Market Cap 61.522 B
NTRA NASDAQ Natera Inc Fair Value Overvalued Market Cap 53.245 B
RVMD NASDAQ Revolution Medicines Inc Fair Value Fair Market Cap 40.928 B
ONC NASDAQ BeOne Medicines AG DRC Fair Value Fair Market Cap 39.9 B
ALNY NASDAQ Alnylam Pharmaceuticals Inc Fair Value Fair Market Cap 32.055 B
BIIB NASDAQ Biogen Inc Fair Value Fair Market Cap 31.841 B
ROIV NASDAQ Roivant Sciences Ltd Fair Value Overvalued Market Cap 28.748 B
INSM NASDAQ Insmed Inc Fair Value Fair Market Cap 26.206 B
INCY NASDAQ Incyte Corporation Fair Value Fair Market Cap 25.4 B
BNTX NASDAQ BioNTech SE Fair Value Fair Market Cap 24.131 B
UTHR NASDAQ United Therapeutics Corporation Fair Value Fair Market Cap 21.214 B
GMAB NASDAQ Genmab AS Fair Value Overvalued Market Cap 20.751 B
ASND NASDAQ Ascendis Pharma AS Fair Value Fair Market Cap 15.546 B
NBIX NASDAQ Neurocrine Biosciences Inc Fair Value Undervalued Market Cap 14.864 B